Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

Summary

The goal of this clinical research study is to find the highest safe dose of sorafenib that can be given in combination with radiation therapy to people with lung cancer. The ability of both the study drug and radiation to control the disease will also be studied.

Timeline

Start

2008-01-25

Primary completion

2011-01

Completion

2011-01

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of Accrual.”

Drugs

Indications